This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
European specialty pharmaceuticals company SpePharm Holding BV has raised €7mm ($9.6mm) in Series C money from existing investors TVM Capital, Signet Healthcare, and Paul Capital Healthcare. Funds from the late-stage round will be used for the company's concurrently announced acquisition of worldwide rights (excluding North and South America) to the anthracycline extravasation drug Savene from TopoTarget AS.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?